Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-09-12
2008-03-18
Marschel, Ardin H. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S274000
Reexamination Certificate
active
07345039
ABSTRACT:
Tumor growth and metastases in cancer patients are inhibited by administration of a combination therapy including effective amounts of 5-Fluorouracil and a methylol transfer agent such as taurolidine, taurultam or mixtures thereof.
REFERENCES:
patent: 6303596 (2001-10-01), Morrissey et al.
patent: 6479481 (2002-11-01), Stendel et al.
patent: 1 066 830 (2001-01-01), None
patent: WO 92/00743 (1992-01-01), None
Braumann, C., et al., “The Influence of Intraoperative Intravenous and Intraperitoneal Application of Taurolidine with Heparin on Subcutaneous and Intraperitoneal Tumor Growth in Laparoscopic Surgery in a Rat Model”,Department of Surgery, Humboldt-University of Berlin, Campus Chartié Mitte, Schumannstr. 20-21, 10098 Berlin, Germany, Apr. 14th and 15th, 2000, 3 pages.
Carter, S., et al., “Chemotherapy of Cancer”, Second Edition, A Wiley Medical Publication, pp. 77-78.
Foye, W., “Cancer Chemotherapeutic Agents”,American Chemical Society, Washington, DC, 1995, pp. 50-55.
Jacobi, C.A., et al., “Intraperitoneal Instillation of Taurolidine and Heparin for the Prevention of intraperitoneal Tumor Growth and Trocar Metastases in Laparoscopic Surgery in a Rat Model”,Langebecks Arch Chir, (1997) 382 Suppl. 1: S31-S36.
Jacobi, C.A., et al., “Influence of Different Gases and Intraperitoneal Instillation of Antiadherent or Cytotoxic Agents on Peritoneal Tumor Cell Growth and Implantation with Laparoscopic Surgery in a Rat Model”,Surg Endosc, (1999) 13:1021-1025.
Jacobi, C.A., et al., “New Therapeutic Strategies to Avoid Intra-and Extraperitoneal Metastases during Laparoscopy: Results of a Tumor Model in the Rat”,Dig Surg, 1999; 16:393-399.
Jacobi, C.A., et al., “Inhibition of Peritoneal Tumor Cell Growth and Implantation in Laparoscopic Surgery in a Rat Model”,The American Journal of Surgery, (1997) vol. 174, pp. 359-363.
Hansen, L., et al., “Altretamine”,DICP, The Annals of Pharmacotherapy, 1991, vol. 25, 146-152.
Parfitt, K., “Martindale, the complete drug reference, 32nd ed”, (formerly Martindale the extra pharmacopoeia), London: Pharmaceutical press, GB, 534-537.
Pfirrmann Rolf W.
Redmond H. Paul
Anderson James D.
Ed. Geistlich Soehne AG fuer chemische Industrie
Marschel Ardin H.
Rothwell Figg Ernst & Manbeck P.C.
LandOfFree
Enhancement of effectiveness of 5-fluorouracil in treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhancement of effectiveness of 5-fluorouracil in treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of effectiveness of 5-fluorouracil in treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3976666